Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Praneeth Jarugula

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Antimicrobial Agents and Chemotherapy|March 16, 2022
Optimizing Vancomycin Dosing and Monitoring in Neonates and Infants Using Population Pharmacokinetic ModelingPraneeth Jarugula, Ayse Akcan-Arikan, Flor Munoz-Rivas, et al.
Journal of Clinical Pharmacology|June 29, 2021
Understanding the Role of Pharmacometrics-Based Clinical Decision Support Systems in Pediatric Patient Management: A Case Study Using Lyv SoftwarePraneeth Jarugula, Sarah Scott, Vijay Ivaturi, et al.
Antimicrobial Agents and Chemotherapy|December 1, 2020
Evaluation of Linezolid Pharmacokinetics in Critically Ill Obese Patients with Severe Skin and Soft Tissue InfectionsAlison L Blackman, Praneeth Jarugula, David P Nicolau, et al.
Clinical and Translational Science|October 25, 2024
Absolute oral bioavailability of milvexian spray-dried dispersion formulation under fasted and fed conditions in healthy adult participants: An intravenous microtracer approachPraneeth Jarugula, Sharif Soleman, Hyunmoon Back, et al.
Clinical Pharmacology and Therapeutics|April 30, 2025
Modeling and Simulation to Inform Apixaban Dosing in Pediatrics With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Treated With AsparaginasePraneeth Jarugula, Toni Ajavon-Hartmann, Obinna Obianom, et al.
Clinical Pharmacology and Therapeutics|June 24, 2025
Characterization of Apixaban Pharmacokinetics/Pharmacodynamics and Dose Assessment in Pediatric Patients with Congenital or Acquired Heart DiseaseAntoinette Ajavon-Hartmann, Praneeth Jarugula, Hyunmoon Back, et al.
Journal of the American College of Cardiology|November 11, 2025
Danicamtiv, a Selective Agonist of Cardiac Myosin, for Dilated Cardiomyopathy: A Phase 2 Open-Label TrialNeal K Lakdawala, Ray E Hershberger, Pablo Garcia-Pavia, et al.
Journal of the American College of Cardiology|December 6, 2023
Apixaban for Prevention of Thromboembolism in Pediatric Heart DiseaseR Mark Payne, Kristin M Burns, Andrew C Glatz, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|March 16, 2022
Optimizing Vancomycin Dosing and Monitoring in Neonates and Infants Using Population Pharmacokinetic ModelingPraneeth Jarugula, Ayse Akcan-Arikan, Flor Munoz-Rivas, et al.
Journal of Clinical Pharmacology|June 29, 2021
Understanding the Role of Pharmacometrics-Based Clinical Decision Support Systems in Pediatric Patient Management: A Case Study Using Lyv SoftwarePraneeth Jarugula, Sarah Scott, Vijay Ivaturi, et al.
Antimicrobial Agents and Chemotherapy|December 1, 2020
Evaluation of Linezolid Pharmacokinetics in Critically Ill Obese Patients with Severe Skin and Soft Tissue InfectionsAlison L Blackman, Praneeth Jarugula, David P Nicolau, et al.
Clinical and Translational Science|October 25, 2024
Absolute oral bioavailability of milvexian spray-dried dispersion formulation under fasted and fed conditions in healthy adult participants: An intravenous microtracer approachPraneeth Jarugula, Sharif Soleman, Hyunmoon Back, et al.
Clinical Pharmacology and Therapeutics|April 30, 2025
Modeling and Simulation to Inform Apixaban Dosing in Pediatrics With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Treated With AsparaginasePraneeth Jarugula, Toni Ajavon-Hartmann, Obinna Obianom, et al.
Clinical Pharmacology and Therapeutics|June 24, 2025
Characterization of Apixaban Pharmacokinetics/Pharmacodynamics and Dose Assessment in Pediatric Patients with Congenital or Acquired Heart DiseaseAntoinette Ajavon-Hartmann, Praneeth Jarugula, Hyunmoon Back, et al.
Journal of the American College of Cardiology|November 11, 2025
Danicamtiv, a Selective Agonist of Cardiac Myosin, for Dilated Cardiomyopathy: A Phase 2 Open-Label TrialNeal K Lakdawala, Ray E Hershberger, Pablo Garcia-Pavia, et al.
Journal of the American College of Cardiology|December 6, 2023
Apixaban for Prevention of Thromboembolism in Pediatric Heart DiseaseR Mark Payne, Kristin M Burns, Andrew C Glatz, et al.
Pageof 1